メディカル・インフォメーションセンター

Medicine & Life Sciences

1. Japan 100%
2. Telemedicine 25%
3. Health 24%
4. Delivery of Health Care 19%
5. Cohort Studies 17%
6. Polychlorinated Biphenyls 16%
7. Critical Pathways 16%
8. Machine Learning 16%
9. Mortality 16%
10. Bangladesh 15%
11. Serum 14%
12. Databases 14%
13. Diabetes Mellitus 12%
14. Smoking 11%
15. Colorectal Neoplasms 11%
16. Confidence Intervals 11%
17. Telecommunications 10%
18. Technology 10%
19. Lung Neoplasms 10%
20. Internet 10%
21. Non-Small Cell Lung Carcinoma 10%
22. Oxaliplatin 9%
23. Demography 9%
24. Dioxins 9%
25. Personal Health Records 9%
26. Prescriptions 9%
27. Therapeutics 9%
28. Cohort Effect 9%
29. Population 9%
30. Neoplasms 9%
31. Occupational Groups 9%
32. Medical Records 9%
33. Coronary Artery Disease 9%
34. Insulin 9%
35. Glucose 8%
36. Liver 8%
37. Multicenter Studies 8%
38. Type 2 Diabetes Mellitus 8%
39. Depression 8%
40. Regression Analysis 8%
41. Polychlorinated Dibenzofurans 7%
42. Odds Ratio 7%
43. Bevacizumab 7%
44. Lipids 7%
45. 2,3,4,7,8-pentachlorodibenzofuran 7%
46. Maternal Health 7%
47. Electronic Health Records 7%
48. Stroke 7%
49. Noncommunicable Diseases 7%
50. Adjuvant Chemotherapy 7%
51. Survival 6%
52. Insulin Resistance 6%
53. Body Mass Index 6%
54. Learning Health System 6%
55. Caregivers 6%
56. University Hospitals 6%
57. Chronic Renal Insufficiency 6%
58. Cerebral Infarction 6%
59. Child Health 6%
60. Datasets 6%
61. Information Services 6%
62. Logistic Models 6%
63. Colonic Neoplasms 6%
64. Stomach Neoplasms 6%
65. Fluorouracil 6%
66. Alcohol Drinking 6%
67. Life Style 6%
68. Safety 5%
69. Bilirubin 5%
70. Age Groups 5%
71. Leucovorin 5%
72. Low Birth Weight Infant 5%
73. Endoscopy 5%
74. Hyperproinsulinemia 5%
75. Medically Unexplained Symptoms 5%
76. Tea 5%
77. Suicidal Ideation 5%
78. Vital Statistics 5%
79. Drug Therapy 5%
80. Clinical Studies 5%
81. Anesthetics 5%
82. Cross-Sectional Studies 5%
83. Cholesterol 5%
84. Education 5%
85. Dyslipidemias 5%
86. Pharmaceutical Preparations 5%
87. Yusho Disease 5%
88. Disease Management 5%
89. Pancreatic Intraductal Neoplasms 5%